EUROPEAN ME NETWORK (EUROMENE) Expert Consensus on the Diagnosis, Service Provision and Care of People with ME/CFS in Europe

Designed by a group of ME/CFS researchers and health professionals, the European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE) has received funding from the European Cooperation in Science and Technology (COST) (https://www.cost.eu/cost-actions/what-are-costactions/ ) COST action 15111 from 2016 to 2020. The main goal of the Cost Action was to assess the existing fragmented knowledge and experience on health care delivery for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in European countries, and to enhance coordinated research and health care provision in this field. We report on the recommendations for clinical diagnosis, heath services and care for people with ME/CFS in Europe, as prepared by the group of clinicians and researchers from 22 countries and 55 European health professionals and researchers, who have been informed by people with ME/CFS (https://www.cost.eu/actions/CA15111/#tabs|Name:overview).

[1]  N. Sepúlveda,et al.  Recommendations for Epidemiological Research in ME/CFS from the EUROMENE Epidemiology Working Group , 2020 .

[2]  A. Michos,et al.  Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2020, Frontiers in Neurology.

[3]  T. Clark,et al.  How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS , 2020, Frontiers in Neurology.

[4]  D. Hughes,et al.  The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE) , 2020, Healthcare.

[5]  L. Jason,et al.  A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain , 2019, American journal of social sciences and humanities.

[6]  S. Sekulic,et al.  Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union , 2019, PloS one.

[7]  K. Norman,et al.  Anti-Inflammatory Diets and Fatigue , 2019, Nutrients.

[8]  L. Aliste,et al.  Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain , 2019, BMC Public Health.

[9]  M. Ariza,et al.  Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. , 2019, Clinical therapeutics.

[10]  T. Clark,et al.  Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study , 2019, Diagnostics.

[11]  K. Rowe.  Long Term Follow up of Young People With Chronic Fatigue Syndrome Attending a Pediatric Outpatient Service , 2019, Front. Pediatr..

[12]  C. Lapp.  Initiating Care of a Patient With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) , 2019, Front. Pediatr..

[13]  L. Nacul,et al.  Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study , 2019, Health expectations : an international journal of public participation in health care and health policy.

[14]  A. DeMaria,et al.  Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning , 2019, Front. Pediatr..

[15]  T. Clark,et al.  Hand Grip Strength as a Clinical Biomarker for ME/CFS and Disease Severity , 2018, Front. Neurol..

[16]  L. Jason,et al.  The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions , 2018, Front. Pediatr..

[17]  C. Scheibenbogen,et al.  Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review , 2018, BMJ Open.

[18]  L. Nacul,et al.  Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls , 2018, PharmacoEconomics - Open.

[19]  A. Blamire,et al.  Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study , 2017, Open Heart.

[20]  C. Sutton,et al.  Can physical assessment techniques aid diagnosis in people with chronic fatigue syndrome/myalgic encephalomyelitis? A diagnostic accuracy study , 2017, BMJ Open.

[21]  I. Mena,et al.  Myalgic encephalomyelitis: International Consensus Criteria , 2017, Journal of internal medicine.

[22]  K. Rowe,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer , 2017, Front. Pediatr..

[23]  T. Clark,et al.  The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis. , 2017, Open journal of bioresources.

[24]  Philip J Mease,et al.  2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.

[25]  N. Unterwalder,et al.  Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome. , 2015, Human immunology.

[26]  P. Magnus,et al.  Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012 , 2014, BMC Medicine.

[27]  J. Alegre,et al.  Impacto de la fibromialgia en el sindrome de fatiga cronica , 2014 .

[28]  Frank N M Twisk.  The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups , 2014, Front. Physiol..

[29]  R. Ferrari,et al.  A Questionnaire Using the Modified 2010 American College of Rheumatology Criteria for Fibromyalgia: Specificity and Sensitivity in Clinical Practice , 2013, The Journal of Rheumatology.

[30]  J. Mandrekar,et al.  COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. , 2012, Mayo Clinic proceedings.

[31]  M. Molokhia,et al.  The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers , 2011, BMC public health.

[32]  G. Kennedy,et al.  Physical and Functional Impact of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis in Childhood , 2010, Pediatrics.

[33]  Byron J. Gajewski,et al.  Reliability, Responsiveness, and Validity of the Visual Analog Fatigue Scale to Measure Exertion Fatigue in People with Chronic Stroke: A Preliminary Study , 2010, Stroke research and treatment.

[34]  I. Hickie,et al.  Are Chronic Fatigue and Chronic Fatigue Syndrome Valid Clinical Entities Across Countries and Health-Care Settings? , 2009, The Australian and New Zealand journal of psychiatry.

[35]  L. Jason.  The Energy Envelope Theory and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2008, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[36]  L. Jason,et al.  The Economic impact of ME/CFS: Individual and societal costs , 2008, Dynamic medicine : DM.

[37]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[38]  Suzanne D Vernon,et al.  Cost Effectiveness and Resource Allocation Open Access the Economic Impact of Chronic Fatigue Syndrome , 2022 .

[39]  R. Chervin.  Epworth sleepiness scale? , 2003, Sleep medicine.

[40]  Michael Seid,et al.  PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations , 2001, Medical care.

[41]  Wanda L. Boda,et al.  Gait abnormalities in chronic fatigue syndrome , 1995, Journal of the Neurological Sciences.

[42]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.

[43]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[44]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[45]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[46]  C. Warfield,et al.  The measurement of pain. , 1988, Hospital practice.

[47]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[48]  P. Beighton,et al.  Articular mobility in an African population. , 1973, Annals of the rheumatic diseases.

[49]  M. Molokhia,et al.  RESEARCH ARTICLE Open Access Prevalence of myalgic encephalomyelitis/chronic , 2022 .

[50]  K. Friedman.  Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. , 2015, Military medicine.

[51]  L. Jason,et al.  ME/CFS: A Primer for Clinical Practitioners , 2012 .

[52]  L. Jason,et al.  ME/CFS: A Primer for Clinical Practitioners Members of the IACFS/ME Primer Writing Committee , 2012 .

[53]  D. Bell,et al.  A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome , 2006 .

[54]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[55]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.